Godavari Biorefineries Limited has received reaffirmation of its credit ratings from CARE Ratings Limited, with the rating agency maintaining its assessment of the integrated sugar and bio-based chemicals manufacturer's financial strength. The announcement, made on March 17, 2026, covers the company's comprehensive banking facilities and deposit programs.

Rating Details and Facility Coverage

CARE Ratings has reaffirmed ratings across multiple facility categories for the company:

The total facilities under review amount to ₹835.83 crore, representing a significant portion of the company's banking arrangements. The stable outlook reflects CARE Ratings' expectations that Godavari Biorefineries will generate healthy cash accruals and maintain adequate debt coverage metrics over the medium term.

Financial Performance and Operating Metrics

The rating reaffirmation comes despite challenging industry conditions that have impacted the company's profitability margins. Godavari Biorefineries reported total operating income growth of 11% year-on-year in FY25, reaching ₹1,870.25 crore compared to ₹1,686.67 crore in FY24.

However, the company's PBILDT margin contracted by approximately 238 basis points to 5.55% in FY25, primarily due to deterioration in the distillery segment's profitability. This decline resulted from restrictions on cane diversion to ethanol production, unavailability of molasses, and consistent increases in sugarcane prices against stable sugar and ethanol realizations.

Business Strengths and Diversification

The rating agency highlighted several key strengths supporting the reaffirmation. Godavari Biorefineries operates a fully integrated sugarcane processing facility with diversified revenue streams across sugar, distillery, co-generation, and bio-based chemicals segments. In FY25, sugar contributed 36% of total revenue, distillery operations 31%, and biochemicals 29%, with the balance from power generation.

The company's strategic location in Karnataka and Maharashtra provides access to high-recovery sugarcane producing regions. In FY25, Godavari Biorefineries achieved a gross recovery rate of 10.94%, compared to 10.78% in the previous year, demonstrating operational efficiency.

Capital Structure and Debt Metrics

The company's financial position showed mixed results, with some improvement in capital structure following its initial public offering in Q3FY25. The overall gearing ratio improved significantly to 0.94x as of March 31, 2025, from 2.79x in the previous year, primarily due to substantial prepayment of term loans using IPO proceeds.

Despite these improvements, the total debt to PBILDT ratio of 4.93x in FY25 remains above the rating agency's negative threshold of 3.5x, representing a key rating sensitivity that requires monitoring.

Future Outlook and Growth Initiatives

CARE Ratings expects gradual improvement in the company's metrics with anticipated recovery in profitability. The rating agency noted that reinstatement of sugar exports and diversion of cane for ethanol production in the ongoing sugar season should support performance recovery. Additionally, the company is commissioning a 200 KLPD grain-based distillery facility expected to become operational in Q1 FY27, which will provide operational flexibility and enhance margins through fungible feedstock capacity.

The growing contribution of specialty chemicals within the bio-based chemical division is providing incremental support to revenue and margins. The company's continued research and development investment in specialty chemicals and pharmaceutical applications is expected to provide diversification and margin enhancement over the medium term.

Source: None/Company/INE497S01012/4626f189-4cad-4f8b-a980-1a703d2c3b2e.pdf

Godavari Biorefineries has announced ambitious growth plans targeting a threefold increase in its current EBITDA by 2029. This strategic initiative represents a significant expansion roadmap for the biorefinery company.

Growth Strategy Overview

The company's announcement outlines plans to substantially scale its operations and financial performance over the next several years. The target to triple current EBITDA levels by 2029 indicates a comprehensive growth strategy aimed at enhancing operational efficiency and market presence.

Strategic Implications

This EBITDA growth target reflects Godavari Biorefineries' confidence in its business model and market opportunities within the biorefinery sector. The ambitious timeline suggests the company has identified specific pathways for expansion and operational improvements to achieve these financial objectives.

Market Position

The announcement positions Godavari Biorefineries as a company with significant growth aspirations in the biorefinery industry. The targeted EBITDA expansion indicates the company's commitment to strengthening its financial performance and market competitiveness over the strategic planning horizon.